Skin Treatment (Pharmacies) - Central America

  • Central America
  • Revenue in the Skin Treatment market is projected to reach US$115.90m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.80%, resulting in a market volume of US$168.70m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.19 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in Central America is experiencing steady growth due to increasing customer preferences for skincare products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Skin Treatment (Pharmacies) market in Central America are shifting towards more natural and organic skincare products. Consumers are becoming more conscious about the ingredients used in their skincare products and are opting for products that are free from harmful chemicals. This preference for natural and organic products is driven by the growing awareness of the potential health risks associated with synthetic ingredients. Additionally, customers are also seeking products that address specific skin concerns such as acne, aging, and hyperpigmentation. Trends in the Skin Treatment (Pharmacies) market in Central America include the rising popularity of multi-step skincare routines and the increasing demand for anti-aging products. Influenced by Korean beauty trends, consumers are adopting multi-step skincare routines that involve multiple products such as cleansers, toners, serums, moisturizers, and masks. This trend is driven by the desire for healthier and more youthful-looking skin. Furthermore, the aging population in Central America is driving the demand for anti-aging skincare products. As people age, they become more concerned about wrinkles, fine lines, and sagging skin, leading to an increased demand for products that target these specific concerns. Local special circumstances in Central America, such as the prevalence of a tropical climate, influence customer preferences and market trends in the Skin Treatment (Pharmacies) market. The high humidity and exposure to sunlight in the region contribute to skin issues such as acne, hyperpigmentation, and sun damage. As a result, customers in Central America are more likely to seek skincare products that address these specific concerns. Additionally, the cultural preference for lighter skin tones in some countries in Central America drives the demand for products that offer skin lightening or brightening effects. Underlying macroeconomic factors also contribute to the development of the Skin Treatment (Pharmacies) market in Central America. The region's growing middle class and increasing disposable incomes enable more consumers to afford skincare products. As people's purchasing power increases, they are more likely to invest in skincare products as part of their self-care routine. Furthermore, the expansion of the retail sector and the increasing number of pharmacies in Central America provide easier access to skincare products, driving market growth. In conclusion, the Skin Treatment (Pharmacies) market in Central America is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and organic products, the adoption of multi-step skincare routines, and the demand for anti-aging products are driving market growth. The tropical climate and cultural preferences in the region also influence customer preferences and market trends. Additionally, the growing middle class and increasing disposable incomes in Central America contribute to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)